PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'National Institute for Food and Drug Control, Beijing, 102629, China.\', \'Wuhan Institute of Biological Products, Co., Ltd., Wuhan, 430207, China.\', \'Texas A&M University, College Station, TX, 77843, USA.\', \'National Institute for Food and Drug Control, Beijing, 102629, China. liyuhua@nifdc.org.cn.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41392-022-00950-y
?:hasPublicationType
?:journal
  • Signal transduction and targeted therapy
is ?:pmid of
?:pmid
?:pmid
  • 35322018
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Advances in COVID-19 mRNA vaccine development.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35322018>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35322018>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all